Literature DB >> 16297875

Tissue Prx I in the protection against Fe-NTA and the reduction of nitroxyl radicals.

Junya Uwayama1, Aki Hirayama, Toru Yanagawa, Eiji Warabi, Rika Sugimoto, Ken Itoh, Masayuki Yamamoto, Hiroshi Yoshida, Akio Koyama, Tetsuro Ishii.   

Abstract

Peroxiredoxin I (Prx I) is a key cytoplasmic peroxidase that reduces intracellular hydroperoxides in concert with thioredoxin. To study the role of tissue Prx I in protection from oxidative stress, we generated Prx I-/- mice by gene trapping. We then evaluated the acute-phase tissue damage caused by ferric-nitrilotriacetate (Fe-NTA). Increases in serum aspartate aminotransferase and alanine aminotransferase levels were significantly greater in Prx I-/- than wild-type mice, 4 and 12 h after the injection of Fe-NTA. Using real-time EPR imaging, we examined the reduction of the stable paramagnetic nitroxyl radical 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl in vivo, and found that the half-life of this spin probe in the liver and kidney was significantly prolonged in the Prx I-/- mice. These results demonstrate that Prx I-/- mice have less reducing activity and are more susceptible to the damage mediated by reactive oxygen species in vivo than wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297875     DOI: 10.1016/j.bbrc.2005.10.192

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development.

Authors:  Murli Mishra; Hong Jiang; Lisha Wu; Hedy A Chawsheen; Qiou Wei
Journal:  Cancer Lett       Date:  2015-07-10       Impact factor: 8.679

2.  Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling.

Authors:  Qiou Wei; Hong Jiang; Zhen Xiao; Alyson Baker; Matthew R Young; Timothy D Veenstra; Nancy H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-12       Impact factor: 11.205

Review 3.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

4.  Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.

Authors:  Tetsuro Ishii; Eiji Warabi; Toru Yanagawa
Journal:  J Clin Biochem Nutr       Date:  2012-02-18       Impact factor: 3.114

Review 5.  Cell stress proteins in atherothrombosis.

Authors:  Julio Madrigal-Matute; Roxana Martinez-Pinna; Carlos Ernesto Fernandez-Garcia; Priscila Ramos-Mozo; Elena Burillo; Jesus Egido; Luis Miguel Blanco-Colio; Jose Luis Martin-Ventura
Journal:  Oxid Med Cell Longev       Date:  2012-06-25       Impact factor: 6.543

Review 6.  Knockout Mouse Models for Peroxiredoxins.

Authors:  Young Jae Lee
Journal:  Antioxidants (Basel)       Date:  2020-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.